(December 17, 2013) – Researchers from Beth Israel Deaconess Medical Center (BIDMC) have discovered that an important clue to diagnosing Parkinson’s may lie just beneath the skin. In a study that appeared in Neurology, the investigators reported …

(December 17, 2013) – A new app for intelligent glasses, such as Google Glass, will soon make it possible to improve the gait of patients suffering from Parkinson’s disease and to decrease their risk of falling. Researchers at the University of T …

(December 16, 2013) – Mahlon R. DeLong, MD, Professor of Neurology at Emory University School of Medicine, is one of six recipients of the 2014 Breakthrough Prize in Life Sciences. The $3 million award recognizes excellence in research aimed at curing …

Medtronic recently received FDA approval of updated labeling for DBS for Parkinson’s disease, supporting the growing evidence that Medtronic DBS Therapy, in addition to medication, is associated with benefits over time. These benefits include qua …

(December 10, 2013) – A new study by a movement disorder neurologist at The Ohio State University Wexner Medical Center found that depression improved among patients with Parkinson’s disease who participated in a long-term group exercise program. …

(December 10, 2013) – Stanford University School of Medicine investigators, using a second-generation version of an existing deep-brain-stimulation, or DBS, have successfully implanted and recorded data that not only generates electrical impulses to ta …

The Parkinson Alliance reports findings pertaining to falls in Parkinson’s on DBS4PD.orgKINGSTON, N.J., December 12, 2013—New findings from The Parkinson Alliance (PA) show that falls are highly prevalent in Parkinson’s disease (PD) a …

(December 5, 2013) – To inform ongoing and future efforts in Parkinson’s disease (PD) research, NINDS will hold the “Parkinson’s Disease 2014: Advancing Research, Improving Lives” conference, on January 6 and 7, 2014 at the Natc …

(December 3, 2013) – Researchers at National Institute of Neurological Disorders and Stroke have used RNA interference (RNAi) technology to reveal dozens of genes which may represent new therapeutic targets for treating Parkinson’s disease. Read …

(December 2, 2013) – Scientists at UCLA and Emory have, for the first time, identified a biochemical signal in the blood associated with the faster-progressing form of Parkinson’s. Such a biomarker could help doctors predict early on how rapidly the di …

(December 2, 2013) – A team of researchers has brought new clarity to the picture of how gene-environmental interactions can kill nerve cells that make dopamine. For the first time, they have used human stem cells derived from Parkinson’s disease patie …

(November 20, 2013) – The ClearPoint Neurosurgical Platform represents an alternative to conventional awake surgery for veterans with Parkinson’s disease. MRI Interventions, Inc. announced that Veterans Affairs Medical Center (VAMC) in San Franci …

New Parkinson’s Disease Genes Discovered by the Parkinson’s Institute and Clinical Center and Population Diagnostics, Inc. (via PR Newswire)Collaborative Effort to Further Validate Genetic Variants SUNNYVALE, Calif. and MELVILLE, N.Y., Nov. 20, 2013 /P …

(November 20, 2013) – US WorldMeds, LLC, has launched a final phase III clinical trial to investigate the use of Myobloc (rimabotulinumtoxinB) injection to treat sialorrhea, commonly known as “drooling.” This “drooling” is commo …

The Michael J. Fox Foundation Expands Fox Trial Finder To Help Accelerate Parkinson’s Trials Worldwide (via PR Newswire)Online tool now a global resource to clinical teams and trial volunteers NEW YORK, Nov. 13, 2013 /PRNewswire-USNewswire/ — Today, T …